Science News features UC researcher on youth anxiety
Jeffrey Strawn, MD, among experts looking at therapies for young brains
The latest issue of Science News looks at anxiety in preschoolers and features the comments of psychiatrist Jeffrey Strawn, MD, an associate professor in the College of Medicine and director of UC's Anxiety Disorders Research Program.
The article estimates that 10 to 20% of U.S. preschoolers suffer from one of several anxiety disorders.
While Strawn doesn't advocate medication for all anxious kids, he says in difficult cases, medication can be appropriate for even younger children.
Strawn's recent research examines common medications prescribed for children and adolescents with anxiety disorders, to determine which are the most effective and best-tolerated.
Featured image: Jeffrey Strawn, MD, associate professor of psychiatry and pediatrics. Photo / AHC Communication Services.
Related Stories
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
Study: There might be 3 different types of ADHD
March 4, 2026
The University of Cincinnati's Melissa DelBello was featured in a National Geographic article discussing recent research she coauthored that used brain imaging to identify three distinct subtypes of of ADHD, each with its own chemical interactions in the brain.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.